Gerry Gajadharsingh writes: “Following on from my recent blog about adverse effects from taking PPI’s, the following research is flagging up additional risks for patients taking GLP1 agonists e.g., Semaglutide or liraglutide, especially in relation to weight reduction.  Patients taking either of these glucagon-like peptide-1 (GLP-1) receptor agonists had nine times an elevated risk for [...]

Gerry Gajadharsingh writes: "The Danish study, explained below. looked at almost 2,000,000 individuals, aged 60 to 75 years between 2000 and 2018. The risk for dementia before age 90 years was significantly higher among people with a history of proton pump inhibitor (PPI) use and was highest among those diagnosed before age 70 years [...]

Those who struggle with agonising headaches could be offered the medication. Gerry Gajadharsingh writes: “Calcitonin gene-related peptide (CGRP inhibitors) in the form of monoclonal antibody injections (monthly) have been offered for a while for potential migraine prevention. CGRP inhibitors block the effect of CGRP, which is a small protein that is highly prevalent in [...]

Gerry Gajadharsingh writes: “With the exception of the recent accelerated approval of aducanumab, in over 26 years of research and development (R&D) investment in Alzheimer's disease (AD), only five novel drugs—all for symptomatic treatment only—have reached FDA approval in the USA. In the USA alone since 1995, $42 Billion has been spent on Alzheimer’s [...]

Gerry Gajadharsingh writes: “Olfactory dysfunction is the first symptom of Alzheimer’s disease (AD) and is also found in virtually all neurological and psychiatric disorders. Donald Wilson, PhD, professor of child and adolescent psychiatry and of neuroscience and physiology, the Child Study Centre, NYU Langone Medical Centre, New York, said that multiple studies have "demonstrated that problems [...]

Products including breakfast cereals, protein bars, low fat yoghurt and supermarket sliced bread linked to heart attacks and stroke. Gerry Gajadharsingh writes: “The findings from two separate research projects below, add to a growing body of evidence linking ultra-processed food to heart disease, heart attacks, strokes, cancer, depression and diabetes. A study from China [...]

Gerry Gajadharsingh writes: The below article is written by an eminent MD, George D Lundberg and boy he is not holding back, a man to my heart!  In 2020 about 11% of the US population was diagnosed with Type 2 diabetes and 42% were obese. In 200 it was 6.2% and 30.5%, in 19080 [...]

Gerry Gajadharsingh writes: “A scientific review by researchers in Spain confirms the negative influence of artificial sweeteners on several primary cardiovascular risk factors. It also shows evidence that these products are not beneficial for controlling excess weight.  The detrimental effects of a high-calorie, high-sugar diet have been well established. For this reason, health authorities recommend [...]

Gerry Gajadharsingh writes: I remember reading Dr John Sano’s, excellent book “Healing Back Pain” over 30 years ago, which at the time, really challenged my paradigm in regard to the diagnosis of musculoskeletal (MSK) pain, especially back pain and therefore it’s treatment. As a specialist in rehabilitation in New York, Sarno’s conclusions, after many [...]

There are believed to be many benefits to slow, controlled breathing. Researchers may have found another – a surprising protection against Alzheimer's. Gerry Gajadharsingh writes: “I am not surprised, but it’s good to see more research backing up sound scientific principles of optimising breathing patterns and heart rate variability (HRV). Prior to the pandemic, [...]